Catalyst Tracker
05/16/2024 04:48 PM ET
Avenue Therapeutics ATXI date announcement
Now that the Phase 1/2 trial of AJ201 is completed, Avenue Therapeutics will announce their top-line results on June 30, 2024. As of now, the drug has a 65.1% chance of moving on.
While investors [...]
Read More
05/16/2024 04:48 PM ET
Dermata Therapeutics BYSI results announcement
BeyondSpring has released new information on their trial for RBM39 degrader. Our analysts provided the following summary:
"IND planned for early 2025."
Investors were pleased with the news, but not enough to significantly [...]
Read More
05/16/2024 04:48 PM ET
Ascendis Pharma A/S ASND date announcement
Ascendis Pharma A/S already had ten catalyst announcements coming up, but they added another one today. It has an announcement scheduled for May 23, 2024 regarding their recent Approved trial of Breyanzi (lisocabtagene maraleucel) - [...]
Read More
05/16/2024 04:48 PM ET
Eyenovia IONS date announcement
After specifying an announcement date for BIIB105 (ATXN2 ASO) - (ALSpire) trial results, Ionis Pharmaceuticals now has nine catalyst announcements planned. On August 31, 2024, Ionis Pharmaceuticals will announce top-line results for their recent Phase [...]
Read More
05/16/2024 04:48 PM ET
Replimune Group REPL earnings announcement
Replimune Group revealed their most recent quarterly earnings data for Q4. EPS was estimated to be -$0.79 and came in right around that value at -$0.82. Replimune Group's EPS is now down $0.08 (-10.8%) over [...]
Read More
05/16/2024 04:48 PM ET
AIM ImmunoTech AIM earnings announcement
AIM ImmunoTech revealed their most recent quarterly earnings data, in which EPS ended up lower than estimates. EPS was estimated to be -$0.11, but the actual figure came in at -$0.12. That is $0.04 (-50%) [...]
Read More
05/16/2024 04:48 PM ET
Dermata Therapeutics IKT earnings announcement
Inhibikase Therapeutics revealed their most recent quarterly earnings data, in which EPS ended up higher than estimates. EPS was reported to be -$0.73, which beat the estimated value of -$0.79. That is $0.23 [...]
Read More
05/16/2024 04:48 PM ET
Aileron Therapeutics ALRN earnings announcement
Aileron Therapeutics revealed their most recent quarterly earnings data for Q1. EPS was reported to be -$0.86.
Aileron Therapeutics edged down $0.05 (-1.28%) to $3.85 on light volume today. Despite that decrease, it is
Read More
05/16/2024 04:47 PM ET
Dermata Therapeutics ATNF earnings announcement
180 Life Sciences revealed their most recent quarterly earnings data for Q1. EPS was reported to be -$1.68.
Investors weren’t very happy with the news. 180 Life Sciences decreased significantly, dropping $0.29 (-14.9%) to $1.65 [...]
Read More
05/16/2024 04:47 PM ET
Eyenovia CNSP earnings announcement
CNS Pharmaceuticals revealed their most recent quarterly earnings data for Q1. EPS was reported to be -$0.41. That is the highest it has been in our dataset.
The market responded well to the news. CNS [...]
Read More
05/16/2024 04:47 PM ET
GT Biopharma GTBP earnings announcement
GT Biopharma revealed their most recent quarterly earnings data, in which EPS ended up higher than estimates. EPS was estimated to be -$2.70 and the actual figure came in at -$1.64.
Closing price zoomed up [...]
Read More
